| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel platelet activating factor receptor antagonist
|
Winslow, C.M.
|
|
1985
|
30 |
4 |
p. 697-
1 p.
|
artikel
|
| 2 |
A platelet-activating factor (PAF) receptor antagonist which influences the primary physiological responses of rodents to PAF
|
Winslow, C.M.
|
|
1985
|
30 |
4 |
p. 698-
1 p.
|
artikel
|
| 3 |
A synthetic pseudolignan derivative as potent and specific PAF-acether receptor antagonist
|
Hwang, S.-B.
|
|
1985
|
30 |
4 |
p. 689-
1 p.
|
artikel
|
| 4 |
A tentative modilisation of PAF-acether (platelet-activating factor) binding site deduced from A.Q.S.A.R. study
|
|
|
1985
|
30 |
4 |
p. 686-
1 p.
|
artikel
|
| 5 |
Beneficial effects of CV-3988, a specific PAF antagonist, in endotoxin and anaphylactic shock
|
Nishikawa, Kohei
|
|
1985
|
30 |
4 |
p. 715-
1 p.
|
artikel
|
| 6 |
BN 52021 and related compounds: A new series of highly specific paf-acether receptor antagonists
|
Braquent, Pierre
|
|
1985
|
30 |
4 |
p. 687-
1 p.
|
artikel
|
| 7 |
Calcium channel blocking drugs: A structural lead for PAF antagonists?
|
Tuffin, D.P.
|
|
1985
|
30 |
4 |
p. 702-
1 p.
|
artikel
|
| 8 |
Comparative physiological effects of PAF and teh PAF antagonist CV-3988 in non-human primates
|
Handley, D.A.
|
|
1985
|
30 |
4 |
p. 695-
1 p.
|
artikel
|
| 9 |
Comparison of BN 52021, a new inhibitor of PAF-acether-induced platelet aggregation, with kadsurenone and CV 3988
|
Chignard, M.
|
|
1985
|
30 |
4 |
p. 701-
1 p.
|
artikel
|
| 10 |
Cyclic adenosine 3′5′ monophosphate stimulates prostaglandin E production by human adherent synovial cells
|
Baker, D.G.
|
|
1985
|
30 |
4 |
p. 669-682
14 p.
|
artikel
|
| 11 |
Cytoprotective and antisecretory properties of a non-diarrheogenic and non-uterotonic prostacyclin analog: U-68, 215
|
Robert, A.
|
|
1985
|
30 |
4 |
p. 619-649
31 p.
|
artikel
|
| 12 |
Different responses to prostaglandin F2α and E2 in human extra- and intramyometrial arteries
|
Maigaard, Svend
|
|
1985
|
30 |
4 |
p. 599-607
9 p.
|
artikel
|
| 13 |
Down-regulation of β 2-adrenergic receptors by paf-acether and its inhibition by the paf-acether antagonist BN 52021
|
Braquet, P.
|
|
1985
|
30 |
4 |
p. 721-
1 p.
|
artikel
|
| 14 |
Effect of BN 52021 on the vascular actions of PAF-acether and immunoglobulin G aggregates
|
Sánchez-Crespo, M.
|
|
1985
|
30 |
4 |
p. 714-
1 p.
|
artikel
|
| 15 |
Effect of indomethacin, tiaprofenic acid and dicrofenac on rat gastric mucosal damage and content of prostacyclin and prostaglandin E2
|
Kobayashi, Kenzo
|
|
1985
|
30 |
4 |
p. 609-618
10 p.
|
artikel
|
| 16 |
Effect of PAF-acether antagonists, RP 48740 and BN 52021, on platelet activation and bronchoconstruction induced by PAF-acether and structural analogues in guinea-pig
|
Coëffier, Eliane
|
|
1985
|
30 |
4 |
p. 699-
1 p.
|
artikel
|
| 17 |
Effect of platelet activating factor of renal hemodynamics and sodium excretion
|
Plante, Gérard E.
|
|
1985
|
30 |
4 |
p. 708-
1 p.
|
artikel
|
| 18 |
Effect of potential antagonists on the rat paw oedema induced by PAF-acether
|
Cordeiro, R.
|
|
1985
|
30 |
4 |
p. 729-
1 p.
|
artikel
|
| 19 |
Effects of BN 52021 on hemodynamics on rats with experimental cirrhosis of the liver
|
Villamediana, L.M.
|
|
1985
|
30 |
4 |
p. 717-
1 p.
|
artikel
|
| 20 |
Electrophysiological consequences of platelet-activating factor (paf-acether) applied on rat isolated retina
|
Doly, M.
|
|
1985
|
30 |
4 |
p. 722-
1 p.
|
artikel
|
| 21 |
Inhibition of an IUD-induced precocious luteolysis by prostaglandin E1 (PGE1) in sheep
|
Weems, C.
|
|
1985
|
30 |
4 |
p. 573-580
8 p.
|
artikel
|
| 22 |
Inhibition of in vivo and in vitro pulmonary effects of paf-acether by BN 52021
|
Touvay, C.
|
|
1985
|
30 |
4 |
p. 719-
1 p.
|
artikel
|
| 23 |
Inhibition of macrophage chemiluminescence induced by PAF and opsonized zymosan
|
Parnham, M.J.
|
|
1985
|
30 |
4 |
p. 705-
1 p.
|
artikel
|
| 24 |
Inhibition of platelet activating factor: Synthesis and biological activity of SRI 63-073, a new phospholipid PAF-acether antagonist
|
Lee, Mark L.
|
|
1985
|
30 |
4 |
p. 690-
1 p.
|
artikel
|
| 25 |
Inhibition of soybean lipoxygenase by SKF 525-A and metyrapone
|
Pretus, Henry A.
|
|
1985
|
30 |
4 |
p. 591-598
8 p.
|
artikel
|
| 26 |
Inhibition of the vascular effect of PAF-acether
|
Pirotzky, E.
|
|
1985
|
30 |
4 |
p. 709-
1 p.
|
artikel
|
| 27 |
Interaction of BN 52021 and PAF-acether with membrane ion transport
|
Garay, Ricardo
|
|
1985
|
30 |
4 |
p. 712-
1 p.
|
artikel
|
| 28 |
Interference of PAF-acether antagonists with platelet aggregation and with the formation of platelet thrombi
|
Hadváry, P.
|
|
1985
|
30 |
4 |
p. 694-
1 p.
|
artikel
|
| 29 |
Interference of PAF-acether antagonists with the effects of PAF itself and of anaphylactic shock in in vitro and in vivo guinea-pig bronchopulmonary
|
Lagente, V.
|
|
1985
|
30 |
4 |
p. 703-
1 p.
|
artikel
|
| 30 |
Introduction
|
|
|
1985
|
30 |
4 |
p. 684-685
2 p.
|
artikel
|
| 31 |
In vitro models for studying drug modulation of paf-acether effects
|
Brunelleschi, S.
|
|
1985
|
30 |
4 |
p. 728-
1 p.
|
artikel
|
| 32 |
In vivo arterial thrombosis and endogenous paf-acether
|
Bourgain, R.H.
|
|
1985
|
30 |
4 |
p. 725-
1 p.
|
artikel
|
| 33 |
In vivo inhibition of plasma protein leakage and endotoxin-induced mortality in the rat by a specific PAF-acether receptor antagonist: BN 52021
|
Etienne, A.
|
|
1985
|
30 |
4 |
p. 716-
1 p.
|
artikel
|
| 34 |
Isolation and characterization of endogenous PAF (platelet-activating factor)-inhibiting factors (EPIFs) in human and monkey urines
|
Braquet, P.
|
|
1985
|
30 |
4 |
p. 692-
1 p.
|
artikel
|
| 35 |
Ovarian lipoxygenase activity and its regulation by gonadotropin in the rat
|
Reich, Reuven
|
|
1985
|
30 |
4 |
p. 581-590
10 p.
|
artikel
|
| 36 |
PAC-acether antagonists in experimental arterial thrombosis
|
Bourgain, R.H.
|
|
1985
|
30 |
4 |
p. 693-
1 p.
|
artikel
|
| 37 |
Paf-acether antagonistic effects of molsidomine in vitro and in vivo
|
Just, M.
|
|
1985
|
30 |
4 |
p. 723-
1 p.
|
artikel
|
| 38 |
PAF-acether-induced cell activation studied on platelet and mast cell with fluorescent probes: Specific inhibition by a new antagonist, BN 52021
|
Baroggi, N.
|
|
1985
|
30 |
4 |
p. 700-
1 p.
|
artikel
|
| 39 |
PAF antagonism in asthma
|
Deeming, K.
|
|
1985
|
30 |
4 |
p. 706-
1 p.
|
artikel
|
| 40 |
PAF: From agonists to antagonists by synthesis
|
Burri, K.
|
|
1985
|
30 |
4 |
p. 691-
1 p.
|
artikel
|
| 41 |
PAF inhalation induce bronchoconstriction, alveolar macrophage activation and specific desensitization
|
Maridonneau-Parini, I.
|
|
1985
|
30 |
4 |
p. 704-
1 p.
|
artikel
|
| 42 |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse
|
Young, John M.
|
|
1985
|
30 |
4 |
p. 545-551
7 p.
|
artikel
|
| 43 |
Pharmacological modulation of guinea-pig bronchospasm induced by PAF-acether aerosol in vivo
|
Fitzgerald, M.F.
|
|
1985
|
30 |
4 |
p. 707-
1 p.
|
artikel
|
| 44 |
Platelet-activating factor antagonist BN 52021 prolongs experimental cardiac allograft survival
|
Foegh, M.L.
|
|
1985
|
30 |
4 |
p. 718-
1 p.
|
artikel
|
| 45 |
Platelets function in atopy with special reference to platelet-activating factor
|
Szczeklik, A.
|
|
1985
|
30 |
4 |
p. 724-
1 p.
|
artikel
|
| 46 |
Regional hemodynamic actions of platelet activating fator (PAF) in conscious spontaneously hypertensive rats (SHR)
|
Struyker-Boudier, H.A.J.
|
|
1985
|
30 |
4 |
p. 726-
1 p.
|
artikel
|
| 47 |
48 740 R.P. : A specific paf-acether antagonist
|
Sedivy, P.
|
|
1985
|
30 |
4 |
p. 688-
1 p.
|
artikel
|
| 48 |
Specificity of the pharmacological inhibition of PAF-acether induced stimulation of rats polymorphonuclear leukocytes
|
Bureau, M.
|
|
1985
|
30 |
4 |
p. 727-
1 p.
|
artikel
|
| 49 |
Suppression of inflammatory oedema in rabbit skin by two PAF antagonists, 48740RP and L-652731
|
Hellewell, P.G.
|
|
1985
|
30 |
4 |
p. 713-
1 p.
|
artikel
|
| 50 |
The effect of PAF-receptor antagonist Kadsurenone on the cardiovascular effects in the rabbit infused with synthetic platelet-activating factor (PAF)
|
Montrucchio, G.
|
|
1985
|
30 |
4 |
p. 711-
1 p.
|
artikel
|
| 51 |
The effect of suppression of prostaglandin synthesis on renal function in rats with intact and reduced renal mass
|
Rubinger, D.
|
|
1985
|
30 |
4 |
p. 651-668
18 p.
|
artikel
|
| 52 |
The effects of CV3988 on platelet aggregation in vivo
|
Robertson, Deidre
|
|
1985
|
30 |
4 |
p. 696-
1 p.
|
artikel
|
| 53 |
The effects of PAC-acether on the cardiovascular system and their inhibition by a new highly specific receptor antagonist BN 52021
|
Baranès, J.
|
|
1985
|
30 |
4 |
p. 710-
1 p.
|
artikel
|
| 54 |
The effects of thyroxine and methimazole treatment on the synthesis of prostacyclin (PGI2) in the rat
|
Noguchi, Toshikazu
|
|
1985
|
30 |
4 |
p. 553-561
9 p.
|
artikel
|
| 55 |
The VI International Conference on Prostaglandins and related compounds
|
|
|
1985
|
30 |
4 |
p. 541-543
3 p.
|
artikel
|
| 56 |
Three-dimension model for PAF-acether (AGEPC) and for Kadsurenone, a specific PAF-receptor antagonist
|
Dupont, L.
|
|
1985
|
30 |
4 |
p. 720-
1 p.
|
artikel
|
| 57 |
U-60, 257 inhibits O3-induced bronchial hyperreactivity in the guinea pig
|
Murlas, Christopher
|
|
1985
|
30 |
4 |
p. 563-572
10 p.
|
artikel
|
Tijdschrift beschrijving